KOD News and Press, Kodiak Sciences Inc From 11/13/25

2025-11-13 16:50:28 ET More on Kodiak Sciences Kodiak Sciences: Odds May Be Narrowing For Longer Lasting Eye Disease Med Approval Kodiak spikes as J.P. Morgan upgrades on eye disease drug, KSI-101 Kodiak gains as Barclays upgrades on Roche data for eye disease drug ...

Kodiak Sciences Announces Recent Business Highlights and Third Quarter 2025 Financial Results PR Newswire PALO ALTO, Calif. , Nov. 13, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), today reported recent business highlights and financial results for the third quarte...

GRI Bio Inc. (GRI) is expected to report $-1.11 for Q3 2025 Meridian Mining UK Societas (MRRDF) is expected to report $-0.01 for Q3 2025 CaliberCos Inc. (CWD) is expected to report $-0.32 for Q3 2025 BioCorRx Inc (BICX) is expected to report $-0.06 for Q3 2025 Beneficient (BENF) i...

Kodiak Sciences to Present at Upcoming Investor Conferences PR Newswire PALO ALTO, Calif. , Nov. 12, 2025 /PRNewswire/ -- Kodiak Sciences Inc. (Nasdaq: KOD), a precommercial retina focused biotechnology company committed to researching, developing and commercializing transfor...

Follow-up data for Kodiak's KSI-101 from the APEX study showed continued strengthening of clinical effect (≥90% of patients achieving absence of intraretinal and subretinal fluid) through week 20 in macular edema secondary to inflammation (MESI) PR Newswire Meaningful vision...

2025-10-31 09:35:21 ET Shares of Kodiak Sciences Inc. (NASDAQ: KOD) traded at a new 52-week high today and are currently trading at $19.76. So far today, approximately 93,636 shares have been exchanged, as compared to an average 30-day volume of 871.63k shares. Kodiak Sciences Inc.,...

2025-10-24 09:16:06 ET More on Kodiak Sciences Kodiak Sciences: Odds May Be Narrowing For Longer Lasting Eye Disease Med Approval Kodiak gains as Barclays upgrades on Roche data for eye disease drug Seeking Alpha’s Quant Rating on Kodiak Sciences Histo...

2025-10-22 09:50:40 ET Shares of Kodiak Sciences Inc. (NASDAQ: KOD) traded at a new 52-week high today and are currently trading at $18. So far today, approximately 72,022 shares have been exchanged, as compared to an average 30-day volume of 1.31M shares. Kodiak Sciences Inc., a cl...

2025-10-03 11:12:13 ET Kodiak Sciences Inc. (NASDAQ: KOD) is one of today’s top gainers. The company’s shares have moved 13.1% on the day to $15.19. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics ...

2025-09-25 11:06:59 ET Kodiak Sciences Inc. (NASDAQ: KOD) is one of today’s top gainers. The company’s shares have moved 19.82% on the day to $18.56. Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics...